NEW YORK (Reuters Health) – Anti-tumor necrosis factor (TNF) agents do not increase the risk of cancer during the first few years of use for rheumatoid arthritis, according…
NEW YORK (Reuters Health) – The bone anabolic drug teriparatide is more effective than alendronate at increasing bone mineral density (BMD) and preventing vertebral fractures in patients with…
NEW YORK (Reuters Health) – Opioid analgesics should not be used in elderly patients with osteoarthritis even if their pain is severe, because the associated risks are so…
Daniel Mazanec, MD, FACP, FACR, Associate Director, Center for Spine Health Cleveland Clinic, discusses medical acupuncture and its role in western medicine treating headache, musculoskeletal disorders including osteoarthritis.…
NEW YORK (Reuters Health) – New research from France indicates that patients using anti-tumor necrosis factor (TNF) monoclonal antibody therapy are at greater risk for developing tuberculosis than…
Rachel Rohde, Orthopedic Surgeon, discusses the treatment options for basal joint arthritis prior to consultation with an orthopedic surgeon. Sponsored by The Doctor’s Channel
NEW YORK (Reuters Health) – Rituximab (Rituxan) has been implicated in 57 cases of progressive multifocal leukoencephalopathy (PML) in HIV-negative patients diagnosed with hematologic malignancies or autoimmune diseases,…
NEW YORK (Reuters Health) – In a small study of rheumatoid arthritis patients, treatment with the anti-tumor necrosis factor (anti-TNF) agent infliximab appeared to increase the antioxidative capacity…
NEW YORK (Reuters Health) – New research indicates that the sense of smell is attenuated in patients with systemic lupus erythematosus (SLE) and that the extent of the…
NEW YORK (Reuters Health) – Certain women may be at risk of developing systemic lupus erythematosus (SLE) when they start taking combined oral contraceptives, according to investigators at…